We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Review · October 06, 2022

Transitioning From Insulin Therapy to DPP-4 Inhibitors in Patients With Type 2 diabetes

Geriatric nursing (New York, N.Y.)


Additional Info

Disclosure statements are available on the authors' profiles:

Geriatric nursing (New York, N.Y.)
Transitioning from insulin to dipeptidyl-peptidase 4 (DPP-4) inhibitors for type 2 diabetes
Geriatr Nurs 2022 Jul 01;46(2022)86-89, I Hamrick, MJ Goblirsch, WJ Tuan, F Beckham

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading